Preferred Label : sodium salicylate;
MeSH definition : A non-steroidal anti-inflammatory agent that is less effective than equal doses of
ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive
to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the
same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding.
(From AMA Drug Evaluations Annual, 1992, p120);
MeSH synonym : salicylate, sodium;
MeSH CAS label : benzoic acid, 2-hydroxy-, monosodium salt;
MeSH Related Number : 54-21-7 (Sodium salicylate);
Registry Number MeSH : 54-21-7;
Wikipedia link : https://en.wikipedia.org/wiki/Sodium salicylate;
Codes EINECS : 200-198-0;
Is substance : O;
medicament (CISMeF) : O;
UNII : WIQ1H85SYP;
InChIKey : ABBQHOQBGMUPJH-UHFFFAOYSA-M;
Origin ID : D012980;
UMLS CUI : C0037549;
ATC code(s)
Allowable qualifiers
CISMeF manual mappings
Pharmacological action(s)
Record concept(s)
Related MeSH Supplementary Concept(s)
See also
See also inter- (CISMeF)
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
A non-steroidal anti-inflammatory agent that is less effective than equal doses of
ASPIRIN in relieving pain and reducing fever. However, individuals who are hypersensitive
to ASPIRIN may tolerate sodium salicylate. In general, this salicylate produces the
same adverse reactions as ASPIRIN, but there is less occult gastrointestinal bleeding.
(From AMA Drug Evaluations Annual, 1992, p120)
https://reptox.cnesst.gouv.qc.ca/pages/fiche-complete.aspx?no_produit=52712&nom=Salicylate+de+sodium
Canada
toxicological data sheet
sodium salicylate
---
http://www.has-sante.fr/portail/jcms/c_928141/glyco-thymoline
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-03/glycothymoline_-_ct-4549.pdf
2010
France
French
evaluation of the transparency committee
drug combinations
sodium benzoate
sodium salicylate
borax
administration, buccal
borates
thymol
cyclohexanols
monoterpenes
menthol
various
insurance, health, reimbursement
treatment outcome
anti-infective agents, local
borates
cyclohexanols
monoterpenes
Eucalyptol
---